Key publications
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
2021
PLoS Med
Jul 6;18(7):e1003656. doi: 10.1371/journal.pmed.1003656. eCollection 2021 Jul.
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
2022
Nat Microbiol.
2022 Jun;7(6):896-908. doi: 10.1038/s41564-022-01135-7. Epub 2022 May 30.PMID: 35637329
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
2022
EBioMedicine
Oct;84:104270. doi: 10.1016/j.ebiom.2022.104270. Epub 2022 Sep 18.